WHO Ladder, Opioids, Neuropathic Pain & Gout Simplified for MSRA
- examiner mla
- 5 days ago
- 2 min read
Key Points:
1. WHO Analgesic Ladder
Step 1 (Mild Pain): Non-opioid analgesics (e.g. paracetamol, NSAIDs)
Step 2 (Moderate Pain): Weak opioids ± non-opioids (e.g. codeine)
Step 3 (Severe Pain): Strong opioids (e.g. morphine)
Important: For severe pain (e.g. bone metastases), escalate directly to strong opioids.
2. Opioid Use and Contraindications
Morphine Contraindication: Severe acute bronchial asthma
Alternative to Morphine (if excessive sedation): Oxycodone
Fentanyl Patches:
Should be avoided in patients still in pain (not suitable for acute pain due to slow onset)
Not used in neonates
3. Neuropathic Pain Management
First-line: Amitriptyline
Other options: Gabapentin, Carbamazepine (specific for trigeminal neuralgia)
4. Trigeminal Neuralgia
First-line treatment: Carbamazepine
5. Gout
Most commonly affected joint: First metatarsophalangeal joint
First-line for acute gout with PUD history: Oral colchicine
Do NOT stop during acute attack if already established: Allopurinol
Medication increasing risk of gout: Diuretics
Lifestyle modification: Reduce alcohol intake
6. General Pain Management
Bone metastasis pain: Morphine is first-line; bisphosphonates and radiotherapy have adjunct roles.
Muscle spasm pain: Baclofen
Sciatica: Avoid gabapentin
Important Considerations:
WHO analgesic ladder guides systematic pain escalation.
Strong opioids are indicated for cancer-related severe pain directly.
Always check contraindications before opioid prescribing.
Differentiate neuropathic vs nociceptive pain for appropriate pharmacological choices.
NSAIDs are avoided in peptic ulcer patients; colchicine or corticosteroids are safer alternatives for gout.
Do not stop allopurinol during acute gout flares if already established on it.
Diagnostic Approach:
Assess pain severity (mild, moderate, severe).
Identify pain type (nociceptive, neuropathic, mixed).
Evaluate contraindications (e.g. asthma for morphine).
Review current medications and comorbidities (e.g. PUD in gout patients).
Consider cancer-related red flags (e.g. bone metastasis).
Management:
Pain Management Plan
Mild pain: Start with non-opioids (paracetamol ± NSAIDs)
Moderate pain: Add weak opioids (e.g. codeine)
Severe pain: Start strong opioids (morphine; oxycodone as alternative if sedation occurs)
Neuropathic Pain
First-line: Amitriptyline
Specific conditions: Carbamazepine for trigeminal neuralgia
Gout
Acute attack with PUD: Oral colchicine preferred
Avoid stopping: Allopurinol during acute attacks
Long-term: Lifestyle modification (reduce alcohol), urate-lowering therapy if indicated
Bone Pain
Cancer metastasis: Morphine first-line; bisphosphonates and radiotherapy adjuncts
Muscle Spasm
Medication: Baclofen
Comments